Question 1

What specific breathing problems are being studied in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Description Des Troubles Respiratoires Chez Les Patients Suivis Pour Une Sclérose en Plaques (SEP) sévère clinical trial (NCT03339817). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the results of this trial help improve my care?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Description Des Troubles Respiratoires Chez Les Patients Suivis Pour Une Sclérose en Plaques (SEP) sévère clinical trial (NCT03339817). Contact the study team or your healthcare provider for specific answers.

Question 3

What tests will I undergo during the study, and how will they be conducted?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Description Des Troubles Respiratoires Chez Les Patients Suivis Pour Une Sclérose en Plaques (SEP) sévère clinical trial (NCT03339817). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the potential risks or discomforts associated with the tests?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Description Des Troubles Respiratoires Chez Les Patients Suivis Pour Une Sclérose en Plaques (SEP) sévère clinical trial (NCT03339817). Contact the study team or your healthcare provider for specific answers.

Question 5

How will my participation in this trial affect my current treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Description Des Troubles Respiratoires Chez Les Patients Suivis Pour Une Sclérose en Plaques (SEP) sévère clinical trial (NCT03339817). Contact the study team or your healthcare provider for specific answers.

Question 6

Are there any follow-up appointments or additional monitoring required after the study?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Description Des Troubles Respiratoires Chez Les Patients Suivis Pour Une Sclérose en Plaques (SEP) sévère clinical trial (NCT03339817). Contact the study team or your healthcare provider for specific answers.

What this study is about